Madrid, Spain

Modesto Remuiñán



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Modesto Remuiñán: Innovator in Anti-Cancer Research

Introduction

Modesto Remuiñán is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of anti-cancer research through his innovative work on variolin derivatives. His research focuses on developing compounds that show promise in combating various types of cancer.

Latest Patents

Remuiñán holds a patent for "Variolin derivatives as anti-cancer agents." This invention provides variolin derivatives of a specific formula, which exhibit activity against a range of mammalian cancer cell lines. The patent outlines new synthetic routes to both new and known variolin compounds, along with novel intermediates. Additionally, it describes the new antitumor activity of known variolin compounds, showcasing the potential of these derivatives in cancer treatment.

Career Highlights

Modesto Remuiñán is associated with Pharma Mar, S.A., a company dedicated to the research and development of innovative medicines for cancer treatment. His work at Pharma Mar has been instrumental in advancing the understanding and application of variolin derivatives in oncology.

Collaborations

Throughout his career, Remuiñán has collaborated with notable colleagues, including Jonathan Charles Morris and Regan James Anderson. These collaborations have contributed to the advancement of research in the field of anti-cancer agents.

Conclusion

Modesto Remuiñán's contributions to anti-cancer research through his innovative patents highlight the importance of ongoing research in the fight against cancer. His work continues to inspire advancements in the development of effective cancer treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…